Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Shareholders' Equity (Unaudited)

v3.20.4
Condensed Statements of Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Sep. 30, 2019 13,641,805      
Balance at Sep. 30, 2019 $ 136,418 $ 56,976,162 $ 17,820,807 $ 74,933,387
Stock-based compensation expense 240,586 240,586
Issuance of common stock under employee stock purchase plan (in shares) 15,107      
Issuance of common stock under employee stock purchase plan $ 151 169,501 169,652
Exercise of stock options, net of shares exchanged for payment (in shares) 1,000      
Exercise of stock options, net of shares exchanged for payment $ 10 2,570 2,580
Tax withholding related to vesting of restricted stock grants (in shares) (453)      
Tax withholding related to vesting of restricted stock grants $ (4) (5,799) (5,803)
Net income 501,158 501,158
Balance (in shares) at Dec. 31, 2019 13,657,459      
Balance at Dec. 31, 2019 $ 136,575 57,383,020 18,321,965 75,841,560
Balance (in shares) at Sep. 30, 2020 13,649,962      
Balance at Sep. 30, 2020 $ 136,500 57,502,905 25,113,873 82,753,278
Restricted stock issued (in shares) 37,687      
Restricted stock issued $ 377 (377)
Stock-based compensation expense 289,057 289,057
Issuance of common stock under employee stock purchase plan (in shares) 15,011      
Issuance of common stock under employee stock purchase plan $ 150 178,931 179,081
Exercise of stock options, net of shares exchanged for payment (in shares) 25,715      
Exercise of stock options, net of shares exchanged for payment $ 257 (262,727) (262,470)
Tax withholding related to vesting of restricted stock grants (in shares) (469)      
Tax withholding related to vesting of restricted stock grants $ (5) (10,942) (10,947)
Net income 3,163,439 3,163,439
Balance (in shares) at Dec. 31, 2020 13,727,906      
Balance at Dec. 31, 2020 $ 137,279 $ 57,696,847 $ 28,277,312 $ 86,111,438